PAPER
Bicyclo Orthoesters and Bicyclo Amide Acetals from a,a-Difluoroalkylamines
3221
GTO-350RD. Polyols 1, 3 and diethanolamine 4 were purchased
from Tokyo Chemical Industry Co., Ltd. Triol 2 was prepared by
mono-benzoylation of pentaerythritol obtained from Tokyo Chem-
ical Industry Co., Ltd. 2-tert-Butyl-2-hydroxymethylpropane-1,3-
diol (11) was prepared according to the literature.8 Activated alumi-
num oxide (200 mesh) was obtained from Wako Pure Chemicals In-
dustries, LTD. Difluoroalkylamines were prepared from the
corresponding carboxylic amides according to the literature.6
under reduced pressure. The product was isolated by column chro-
matography (activated alumina; hexane–CH2Cl2, 1:1).
Yield: 202 mg (62%); white solid; mp 117–118 °C.
IR (KBr): 2950, 2889, 1735, 1338, 1101 cm–1.
1H NMR (CDCl3): d = 8.03 (d, J = 7.0 Hz, 2 H), 7.65–7.60 (m, 3 H),
7.50–7.46 (m, 2 H), 7.37–7.36 (m, 3 H), 4.31 (s, 6 H), 4.21 (s, 2 H).
13C NMR (CDCl3): d = 165.9, 137.0, 133.6, 129.6 (2 × C), 129.3,
129.1, 128.6 (2 × C), 128.0 (2 × C), 125.6 (2 × C), 108.0, 69.7 (3 ×
C), 62.4, 34.9.
N,N-Diethyl-a,a-difluorobenzylamine (DFBA)
Bp 42–45 °C (0.1 mmHg).
HRMS (FAB): m/z [M + 1] calcd for C19H19O5: 327.1232; found:
327.1231.
1H NMR (CDCl3): d = 7.62–7.59 (m, 2 H), 7.43–7.40 (m, 3 H), 2.90
(q, J = 10.5 Hz, 4 H), 1.06 (t, J = 10.5 Hz, 6 H).
1-Phenyl-4-{[(1-phenyl-2,6,7-trioxabicyclo[2.2.2]octane-4-
yl)methoxy]methyl}-2,6,7-trioxabicyclo[2.2.2]octane (8)
A mixture of 3 (254 mg, 1 mmol) and DFBA (796 mg, 4 mmol) in
anhydrous DMF (1 mL) was stirred at 60 °C for 1 h. The mixture
was poured into sat. aq NaHCO3 (20 mL) and extracted with CH2Cl2
(3 × 20 mL). The combined organic layer was dried (MgSO4) and
concentrated under reduced pressure. Recrystallization from
CH2Cl2–hexane gave the pure product.
N,N-Diethyl-a,a-difluoro-3-methylbenzylamine (DFMBA)
Bp 84–88 °C (5 mmHg).
1H NMR (CDCl3): d = 7.41–7.17 (m, 4 H), 2.92 (q, J = 7.0 Hz, 4 H),
2.39 (s, 3 H), 1.07 (t, J = 7.1 Hz, 6 H).
N-(1,1-Difluoro-2,2-dimethylpropyl)pyrrolidine
Bp 51 °C (7 mmHg).
1H NMR (CDCl3): d = 3.07–3.03 (m, 4 H), 1.80–1.76 (m, 4 H), 1.13
(s, 9 H).
Yield: 409 mg (96%); white solid; mp 210 °C.
IR (KBr): 2883, 1339, 1088 cm–1.
1H NMR (CDCl3): d = 7.63–7.61 (m, 4 H), 7.37–7.35 (m, 6 H), 4.19
(s, 12 H), 3.27 (s, 4 H).
N,N-Diethyl-a,a-difluoro-4-bromobenzylamine
Bp 62–64 °C (0.1 mmHg).
13C NMR (CDCl3): d = 137.1 (2 × C), 129.3 (2 × C), 128.0 (4 × C),
125.6 (4 × C), 107.9 (2 × C), 70.2 (2 × C), 69.8 (6 × C), 35.4 (2 × C).
1H NMR (CDCl3): d = 7.55 (d, J = 8.5 Hz, 2 H), 7.47 (d, J = 8.5 Hz,
2 H), 2.85 (q, J = 7.1 Hz, 4 H), 1.04 (t, J = 7.2 Hz, 6 H).
HRMS (FAB): m/z [M + 1] calcd for C24H27O7: 427.1757; found:
427.1758.
4-Methyl-1-phenyl-2,6,7-trioxabicyclo[2.2.2]octane (5); Typical
Procedure
A mixture of 1 (180 mg, 1.5 mmol) and powdered MS (4 Å; 300
mg) in anhyd DMF (3 mL) was stirred at r.t. for 1 h. The mixture
was cooled to 0 °C and DFBA (199 mg, 1 mmol) was added. After
stirring at r.t. for 2 h, the mixture was poured into sat. aq NaHCO3
(20 mL), and extracted with CH2Cl2 (3 × 20 mL). The combined or-
ganic layer was dried (MgSO4) and concentrated under reduced
pressure. Purification by column chromatography (activated alumi-
na; hexane–Et2O, 1:1) gave 5.
5-(3-Methylphenyl)-1-aza-4,6-dioxabicyclo[3.3.0]octane (9)
To a solution of 4 (788 mg, 7.5 mmol) in CH2Cl2 (3 mL), was added
DFMBA (1.07 g, 5 mmol) at 0 °C, and the mixture was stirred at r.t.
for 30 min. The mixture was poured into sat. aq NaHCO3 (20 mL)
and extracted with CH2Cl2 (3 × 20 mL). The combined organic lay-
er was dried (MgSO4), concentrated under reduced pressure and pu-
rified by Kugelrohr distillation to give 9.
Yield: 810 mg (79%); bp 120 °C (bath temperature) / 0.1 mmHg.
IR (neat): 2882, 1631, 1471, 1300, 1080 cm–1.
Yield: 136 mg (66%); white solid; mp 125–126 °C (Lit.11 128–
129 °C).
1H NMR (CDCl3): d = 7.43–7.41 (m, 1 H), 7.27–7.21 (m, 2 H),
7.14–7.12 (m, 1 H), 4.17–4.09 (m, 2 H), 4.05–3.94 (m, 2 H), 3.43–
3.33 (m, 2 H), 3.15–3.07 (m, 2 H), 2.63 (s, 3 H).
13C NMR (CDCl3): d = 14.00, 137.7, 129.2, 127.9, 126.5, 123.2,
122.9, 65.6 (2 × C), 53.0 (2 × C), 21.4.
IR (KBr): 2881, 1337, 996 cm–1.
1H NMR (CDCl3): d = 7.63–7.61 (m, 2 H), 7.35–7.34 (m, 3 H), 4.10
(s, 6 H), 0.89 (s, 3 H).
13C NMR (CDCl3): d = 137.4, 129.1, 128.0 (2 × C), 125.6 (2 × C),
107.4, 73.2 (3 × C), 30.5, 14.5.
HRMS (EI): m/z calcd for C12H15NO2: 205.1103; found: 205.1104.
1-tert-Butyl-4-methyl-2,6,7-trioxabicyclo[2.2.2]octane (6)
Product was isolated by column chromatography (activated alumi-
na; hexane–Et2O, 1:1).
White sold; mp 94–95 °C (Lit.12 102 °C).
IR (KBr): 2881, 1337, 996 cm–1.
1H NMR (CDCl3): d = 3.86 (s, 6 H), 0.96 (s, 9 H), 0.78 (s, 3 H).
5-Phenyl-1-aza-4,6-dioxabicyclo[3.3.0]octane (10)
Bp 95 °C (bath temperature)/0.1 mmHg (Lit.7a 79–80 °C/0.03
mmHg).
IR (neat): 2883, 1626, 1448, 1281, 1067 cm–1.
1H NMR (CDCl3): d = 7.62–7.60 (m, 2 H), 7.34–7.28 (m, 3 H),
4.13–4.08 (m, 2 H), 4.01–3.96 (m, 2 H), 3.38–3.33 (m, 2 H), 3.11–
3.05 (m, 2 H).
13C NMR (CDCl3): d = 140.2, 128.3, 128.0, 125.9 (2 × C), 123.2
(2 × C), 65.6 (2 × C), 53.0 (2 × C).
13C NMR (CDCl3): d = 111.9, 72.6 (3 × C), 37.3, 30.1, 24.8 (3 × C),
14.5.
4-Benzoyloxymethyl-1-phenyl-2,6,7-trioxabicyclo[2.2.2]octane
(7)
A mixture of 2 (240 mg, 1 mmol) and DFBA (199 mg, 1.5 mmol)
1-(4-Bromophenyl)-4-tert-butyl-2,6,7-trioxabicyclo[2.2.2]oc-
tane (12)
The reaction was carried out as described for 5, to give 12, which
was isolated by column chromatography (activated alumina; hex-
ane–CH2Cl2, 1:1).
in CDCl3 (5 mL) was stirred at 50 °C for 1 h (consumption of 2 was
1
confirmed from H NMR analysis). The mixture was poured into
sat. aq NaHCO3 (20 mL) and extracted with CH2Cl2 (3 × 20 mL).
The combined organic layer was dried (MgSO4) and concentrated
Synthesis 2008, No. 20, 3219–3222 © Thieme Stuttgart · New York